Evidence map›Paper›PMID 34899328›Full record

ArticleFrontiers in pharmacology2021

Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism.

Lu Yang, Liping Bi, Lulu Jin, Yuming Wang, Yuting Li, Zixuan Li, Wenju He, Huantian Cui, Jing Miao, Li Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Arachidonic acid in aging: New roles for old players.Journal of advanced research · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Lu YangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Liping BiTianjin Second People's Hospital, Tianjin, China.
Lulu JinTianjin University of Traditional Chinese Medicine, Tianjin, China.
Yuming WangTianjin University of Traditional Chinese Medicine, Tianjin, China.
Yuting LiTianjin University of Traditional Chinese Medicine, Tianjin, China.
Zixuan LiYunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China.
Wenju HeTianjin First Central Hospital, Tianjin, China.
Huantian CuiShandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, China.
Jing MiaoTianjin Second People's Hospital, Tianjin, China.
Li WangTianjin Second People's Hospital, Tianjin, China.
Tianjin People's Hospital · CNTianjin University of Traditional Chinese Medicine · CNShandong University · CNTianjin First Center Hospital · CNYunnan Provincial Hospital of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis is a progressive liver damage condition caused by various factors and may progress toward liver cirrhosis, and even hepatocellular carcinoma. Many studies have found that the disfunction in metabolism could contribute to the development of liver fibrosis. Geniposide, derived from

Indexed as

apoptosisgeniposideinflammationliver fibrosisoxidative stressuntargeted metabolomic analysis

Identifiers

PMID34899328
PMCPMC8651620
OpenAlexW3214776688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.